SCHEMBL22249686

SCHEMBL22249686

c1ccc2c(c1)oc1cc3c4ccccc4c4ccccc4c3cc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.63
MAPT P10636 5/20 0.57
MEN1 O00255 5/20 0.57
KMT2A Q03164 5/20 0.57
KDM4E B2RXH2 3/20 0.57
ALDH1A1 P00352 3/20 0.57
HPGD P15428 3/20 0.57
NPC1 O15118 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
RAB9A P51151 1/20 0.57
MAOA P21397 3/20 0.55
CYP1A2 P05177 2/20 0.50
GLA P06280 1/20 0.50
CYP3A4 P08684 1/20 0.50
PGAM1 P18669 1/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
HSD17B10 Q99714 1/20 0.50
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24039795 1.00 AHR (0.63) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL571563 0.93 AHR (0.71) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL16919496 0.93 AHR (0.71) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL1635601 0.90 AHR (0.68) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL24362987 0.88 AHR (0.52) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL23260301 0.87 KMT2A (0.53) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL25050934 0.86 MAPT (0.53) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL17563715 0.85 PLA2G2A (0.49) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL24307195 0.84 MAPT (0.65) AHRMAPTMEN1KMT2AKDM4E
Triphenylene SCHEMBL28805069 0.84 MAPT (0.65) AHRMAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11239435-B2 Iridium complex and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200235318-A1 IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235318-A1 IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OPA1, MT-ND5, IMPA1 AHR 4282/4885MAPT 681/4885MEN1 386/4885
US-11239435-B2 Iridium complex and organic electroluminescence device using the same OPA1, MT-ND5, IMPA1 AHR 4282/4885MAPT 681/4885MEN1 386/4885
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ODC1 AHR 2547/4885MAPT 1445/4885MEN1 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.